AGTX - Agentix Corp.

0.05
0   0%

Share volume: 2,500
Last Updated: 04-25-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$0.05
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
36%
Profitability 35%
Dept financing 43%
Liquidity 1%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-16.67%
3 Months
-54.63%
6 Months
-71.75%
1 Year
-71.75%
2 Year
-71.75%
Key data
Stock price
$0.05
P/E Ratio 
0.00
DAY RANGE
$0.05 - $0.05
EPS 
-$0.01
52 WEEK RANGE
$0.04 - $0.20
52 WEEK CHANGE
-$71.75
MARKET CAP 
7.112 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$24,167
AVERAGE 30 VOLUME 
$12,622
Company detail
CEO:
Region: US
Website: agentixcorp.com
Employees: 0
IPO year: 2019
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Agentix Corp. focuses on the development and commercialization of therapeutics to treat metabolic diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix in June 2019.

Recent news
loading